News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
246 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (4)
2 (2)
3 (20)
4 (246)
5 (293)
6 (243)
7 (134)
8 (6)
9 (6)
10 (245)
11 (212)
12 (305)
13 (245)
14 (103)
15 (11)
16 (7)
17 (226)
18 (253)
19 (250)
20 (220)
21 (147)
22 (16)
23 (11)
24 (235)
25 (299)
26 (248)
27 (114)
28 (103)
29 (10)
30 (46)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Drug Development
Top Line Results of the Namodenoson Phase II Advanced Liver Cancer Trial Expected by End of Year
Namodenoson seeks to address a major unmet need for Child Pugh B patients with advanced liver cancer
September 4, 2018
·
7 min read
Genetown
Acceleron to Participate in Three Upcoming September and October 2018 Healthcare Investor Conferences
Acceleron Pharma Inc. today announced that senior management will participate in three upcoming healthcare investor conferences.
September 4, 2018
·
2 min read
Pharm Country
City Harvest Announces Hunger Action Month Partnerships to Raise Awareness of Hunger in New York City
Throughout September, City Harvest and its Partners will Join with Feeding America to Encourage Individuals to Take Action and Help Feed Our Neighbors in Need
September 4, 2018
·
6 min read
Drug Development
Horizon Pharma plc Completes Enrollment of Confirmatory Phase 3 Trial of Teprotumumab Ahead of Schedule
Topline results expected in second quarter of 2019
September 4, 2018
·
5 min read
Job Trends
Planet Fitness Slidell Hosts Open House to Showcase New Equipment and Refreshed Facility
Planet Fitness Slidell is reopening its doors after upgrading the facility and outfitting the club with new equipment. The club is celebrating the renovation with a $2,500 planned donation to the Slidell unit of the Boys and Girls Club of Southeast Louisiana.
September 4, 2018
·
2 min read
Policy
Opioid Justice Team Petition For Opioid Affected Infants And Children To Be Removed From Multi-District Litigation
Attorneys representing class actions filed on behalf of babies who will need life-long medical and other specialized care because of opioid use by their pregnant moms are requesting a specialized panel of federal judges to remove such cases from the Multi-District Litigation (MDL).
September 4, 2018
·
3 min read
Pharm Country
InventHelp Inventor Develops LAMAE (JHA-148)
“While going through chemo I thought there could be a better way to cover and protect ports, catheters and PICC lines,” said an inventor, from Jacksonville, Fla., “so I invented the LAMAE.”
September 4, 2018
·
1 min read
Pharm Country
IPRO-Led Panel Reports Consensus on Anticoagulation Management
An IPRO-led multi-disciplinary panel has reached consensus on essential anticoagulation management elements that need to be communicated to downstream providers upon transition between all health care settings.
September 4, 2018
·
2 min read
Business
Gilead Enters Licensing Agreement With Trianni for Use of Trianni Transgenic Human Monoclonal Antibody Discovery Platform
Gilead Sciences, Inc. (NASDAQ: GILD) and TRIANNI, Inc. (“TRIANNI”) today announced that the companies have entered into a license agreement that grants Gilead the use of the Trianni transgenic human monoclonal antibody discovery platform to support the company’s drug discovery efforts.
September 4, 2018
·
3 min read
Business
RMS Medical Products Announces Appointment of President and Chief Commercial Officer Donald Pettigrew
Repro Med Systems, Inc. dba RMS Medical Products today announced that Donald B. Pettigrew has been appointed to the position of President and Chief Commercial Officer.
September 4, 2018
·
3 min read
Previous
6 of 25
Next